Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

369.14 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Bio-Rad Reports Second-Quarter 2022 Financial Results

July 28, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Tesla, Danaher And Some Other Big Gainers From Yesterday ↗

July 22, 2022

U.S. stocks closed higher on Thursday, with the Nasdaq Composite jumping around 1.4%. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022

July 18, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Jim Cramer Says This Stock Is 'Too Risky' ↗

July 01, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Cadre Holdings Inc (NYSE: CDRE) as it "makes things, does stuff, sells at a profit, gives you money back."

Via Benzinga

Earnings Scheduled For February 10, 2022 ↗

February 10, 2022

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

Via Benzinga

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗

July 22, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...

Via Benzinga

Bio-Rad Publishes Corporate Sustainability Report

June 27, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session ↗

July 21, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending...

Via Benzinga

7 Profitable Places to Hide Your Money During a Bear Market ↗

May 13, 2022

With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification.

Via InvestorPlace

5 Value Stocks To Watch In The Healthcare Sector ↗

May 02, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Recap: Bio-Rad Laboratories Q1 Earnings ↗

April 28, 2022

Bio-Rad Laboratories (NYSE:BIO) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Bio-Rad Reports First-Quarter 2022 Financial Results

April 28, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022

April 18, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Will Investment Gains For Google Parent Reverse In Upcoming Earnings Report? ↗

April 05, 2022

Investment gains have played a big role in earnings beats for GOOGL stock in recent years but that may reverse in its first-quarter earnings.

Via Investor's Business Daily

Overview Of Value Stocks In The Healthcare Sector ↗

March 28, 2022

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead ↗

March 10, 2022

We're taking a gander at more companies that could follow Amazon's (AMZN) lead with potential upcoming stock splits in 2022.

Via InvestorPlace

Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day

February 25, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

7 Stocks To Buy at the Bottom After the Market Rout ↗

February 17, 2022

The recent market rout offers an opportune entry point to these seven robust stocks. These are good stocks to buy at their bottom now.

Via InvestorPlace

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO ↗

February 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...

Via Benzinga

Recap: Bio-Rad Laboratories Q4 Earnings ↗

February 10, 2022

Bio-Rad Laboratories (NYSE:BIO) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results

February 10, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Bio-Rad Laboratories's Earnings: A Preview ↗

February 09, 2022

Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2022-02-10. Here's what investors need to know before the announcement. Analysts estimate that Bio-Rad...

Via Benzinga

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Bio-Rad to Host Investor Day on February 25

February 02, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022

January 25, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Overview Of Value Stocks In The Healthcare Sector ↗

January 24, 2022

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11

January 05, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Free COVID Tests: What Stocks Will Benefit? ↗

December 23, 2021

The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.

Via Talk Markets

Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President

December 16, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.